Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Overview
Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Return on Equity
Return on Equity (ROE) for BLACW.
Get informed when a big investor buys or sells
+ FollowROE
6.22%
Return on Equity
6.22%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Average ROE (Comparison Companies)
ROE History
ROE Comparison